PKM2-IN-1 reduced glucose uptake and lactate production in esophageal and hepatocellular carcinoma cells38,39 and 3PO inhibited growth of lung cancer, breast cancer and promyelocytic leukemia cells14. Here, PKM is linked to acute promyelocytic leukemia.